Vaccine for Diabetes—Where Do We Stand?
Diabetes is an endocrinological disorder with a rapidly increasing number of patients globally. Over the last few years, the alarming status of diabetes has become a pivotal factor pertaining to morbidity and mortality among the youth as well as middle-aged people. Current developments in our unders...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2022-08, Vol.23 (16), p.9470 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 16 |
container_start_page | 9470 |
container_title | International journal of molecular sciences |
container_volume | 23 |
creator | Chellappan, Dinesh Kumar Bhandare, Richie R. Shaik, Afzal B. Prasad, Krishna Suhaimi, Nurfatihah Azlyna Ahmad Yap, Wei Sheng Das, Arpita Banerjee, Pradipta Ghosh, Nandini Guith, Tanner Das, Amitava Balakrishnan, Sarannya Candasamy, Mayuren Mayuren, Jayashree Palaniveloo, Kishneth Gupta, Gaurav Singh, Sachin Kumar Dua, Kamal |
description | Diabetes is an endocrinological disorder with a rapidly increasing number of patients globally. Over the last few years, the alarming status of diabetes has become a pivotal factor pertaining to morbidity and mortality among the youth as well as middle-aged people. Current developments in our understanding related to autoimmune responses leading to diabetes have developed a cause for concern in the prospective usage of immunomodulatory agents to prevent diabetes. The mechanism of action of vaccines varies greatly, such as removing autoreactive T cells and inhibiting the interactions between immune cells. Currently, most developed diabetes vaccines have been tested in animal models, while only a few human trials have been completed with positive outcomes. In this review, we investigate the undergoing clinical trial studies for the development of a prototype diabetes vaccine. |
doi_str_mv | 10.3390/ijms23169470 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9409121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2706261215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-81c831c1d05e829071df2dde575dc770849f7234122adafdc3b67a5525b913993</originalsourceid><addsrcrecordid>eNpdkctKAzEUhoMoVqs7H2DAjYKjJ8lkMtko0nqDggsvXYZMkrFTppOazAjufAif0CdxaotUV-eH8_FxDj9CBxhOKRVwVk5ngVCcioTDBtrBCSExQMo313IP7YYwBSCUMLGNejQFTDhlO-j4WWld1jYqnI-GpcptY8PXx-d4Yr2Nhi4a2-ihUbW52ENbhaqC3V_NPnq6vnoc3Maj-5u7weUo1jQTTZxhnVGssQFmMyKAY1MQYyzjzGjOIUtEwQlNMCHKqMJomqdcMUZYLjAVgvbR-dI7b_OZNdrWjVeVnPtypvy7dKqUfzd1OZEv7k2KBAQmuBMcrQTevbY2NHJWBm2rStXWtUESDjwFDj_o4T906lpfd-8tqJSknY911MmS0t6F4G3xewwGuehArndAvwFdYHbO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2706261215</pqid></control><display><type>article</type><title>Vaccine for Diabetes—Where Do We Stand?</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Chellappan, Dinesh Kumar ; Bhandare, Richie R. ; Shaik, Afzal B. ; Prasad, Krishna ; Suhaimi, Nurfatihah Azlyna Ahmad ; Yap, Wei Sheng ; Das, Arpita ; Banerjee, Pradipta ; Ghosh, Nandini ; Guith, Tanner ; Das, Amitava ; Balakrishnan, Sarannya ; Candasamy, Mayuren ; Mayuren, Jayashree ; Palaniveloo, Kishneth ; Gupta, Gaurav ; Singh, Sachin Kumar ; Dua, Kamal</creator><creatorcontrib>Chellappan, Dinesh Kumar ; Bhandare, Richie R. ; Shaik, Afzal B. ; Prasad, Krishna ; Suhaimi, Nurfatihah Azlyna Ahmad ; Yap, Wei Sheng ; Das, Arpita ; Banerjee, Pradipta ; Ghosh, Nandini ; Guith, Tanner ; Das, Amitava ; Balakrishnan, Sarannya ; Candasamy, Mayuren ; Mayuren, Jayashree ; Palaniveloo, Kishneth ; Gupta, Gaurav ; Singh, Sachin Kumar ; Dua, Kamal</creatorcontrib><description>Diabetes is an endocrinological disorder with a rapidly increasing number of patients globally. Over the last few years, the alarming status of diabetes has become a pivotal factor pertaining to morbidity and mortality among the youth as well as middle-aged people. Current developments in our understanding related to autoimmune responses leading to diabetes have developed a cause for concern in the prospective usage of immunomodulatory agents to prevent diabetes. The mechanism of action of vaccines varies greatly, such as removing autoreactive T cells and inhibiting the interactions between immune cells. Currently, most developed diabetes vaccines have been tested in animal models, while only a few human trials have been completed with positive outcomes. In this review, we investigate the undergoing clinical trial studies for the development of a prototype diabetes vaccine.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23169470</identifier><identifier>PMID: 36012735</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Animal models ; Antigens ; Apoptosis ; Chronic illnesses ; Clinical trials ; Cytokines ; Diabetes ; Diabetes mellitus ; Disease prevention ; Family medical history ; Immune system ; Immunomodulation ; Insulin resistance ; Lymphocytes ; Lymphocytes T ; Medical research ; Morbidity ; Mortality ; Pathogens ; Peptides ; Review ; Tumor necrosis factor-TNF ; Vaccines</subject><ispartof>International journal of molecular sciences, 2022-08, Vol.23 (16), p.9470</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-81c831c1d05e829071df2dde575dc770849f7234122adafdc3b67a5525b913993</citedby><cites>FETCH-LOGICAL-c389t-81c831c1d05e829071df2dde575dc770849f7234122adafdc3b67a5525b913993</cites><orcidid>0000-0002-2609-8849 ; 0000-0002-7507-1159 ; 0000-0001-5567-6663 ; 0000-0002-8665-3074 ; 0000-0002-6745-9815 ; 0000-0003-0466-2602 ; 0000-0002-9036-1963 ; 0000-0003-3823-6572</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409121/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409121/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Chellappan, Dinesh Kumar</creatorcontrib><creatorcontrib>Bhandare, Richie R.</creatorcontrib><creatorcontrib>Shaik, Afzal B.</creatorcontrib><creatorcontrib>Prasad, Krishna</creatorcontrib><creatorcontrib>Suhaimi, Nurfatihah Azlyna Ahmad</creatorcontrib><creatorcontrib>Yap, Wei Sheng</creatorcontrib><creatorcontrib>Das, Arpita</creatorcontrib><creatorcontrib>Banerjee, Pradipta</creatorcontrib><creatorcontrib>Ghosh, Nandini</creatorcontrib><creatorcontrib>Guith, Tanner</creatorcontrib><creatorcontrib>Das, Amitava</creatorcontrib><creatorcontrib>Balakrishnan, Sarannya</creatorcontrib><creatorcontrib>Candasamy, Mayuren</creatorcontrib><creatorcontrib>Mayuren, Jayashree</creatorcontrib><creatorcontrib>Palaniveloo, Kishneth</creatorcontrib><creatorcontrib>Gupta, Gaurav</creatorcontrib><creatorcontrib>Singh, Sachin Kumar</creatorcontrib><creatorcontrib>Dua, Kamal</creatorcontrib><title>Vaccine for Diabetes—Where Do We Stand?</title><title>International journal of molecular sciences</title><description>Diabetes is an endocrinological disorder with a rapidly increasing number of patients globally. Over the last few years, the alarming status of diabetes has become a pivotal factor pertaining to morbidity and mortality among the youth as well as middle-aged people. Current developments in our understanding related to autoimmune responses leading to diabetes have developed a cause for concern in the prospective usage of immunomodulatory agents to prevent diabetes. The mechanism of action of vaccines varies greatly, such as removing autoreactive T cells and inhibiting the interactions between immune cells. Currently, most developed diabetes vaccines have been tested in animal models, while only a few human trials have been completed with positive outcomes. In this review, we investigate the undergoing clinical trial studies for the development of a prototype diabetes vaccine.</description><subject>Animal models</subject><subject>Antigens</subject><subject>Apoptosis</subject><subject>Chronic illnesses</subject><subject>Clinical trials</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Disease prevention</subject><subject>Family medical history</subject><subject>Immune system</subject><subject>Immunomodulation</subject><subject>Insulin resistance</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Medical research</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Pathogens</subject><subject>Peptides</subject><subject>Review</subject><subject>Tumor necrosis factor-TNF</subject><subject>Vaccines</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkctKAzEUhoMoVqs7H2DAjYKjJ8lkMtko0nqDggsvXYZMkrFTppOazAjufAif0CdxaotUV-eH8_FxDj9CBxhOKRVwVk5ngVCcioTDBtrBCSExQMo313IP7YYwBSCUMLGNejQFTDhlO-j4WWld1jYqnI-GpcptY8PXx-d4Yr2Nhi4a2-ihUbW52ENbhaqC3V_NPnq6vnoc3Maj-5u7weUo1jQTTZxhnVGssQFmMyKAY1MQYyzjzGjOIUtEwQlNMCHKqMJomqdcMUZYLjAVgvbR-dI7b_OZNdrWjVeVnPtypvy7dKqUfzd1OZEv7k2KBAQmuBMcrQTevbY2NHJWBm2rStXWtUESDjwFDj_o4T906lpfd-8tqJSknY911MmS0t6F4G3xewwGuehArndAvwFdYHbO</recordid><startdate>20220822</startdate><enddate>20220822</enddate><creator>Chellappan, Dinesh Kumar</creator><creator>Bhandare, Richie R.</creator><creator>Shaik, Afzal B.</creator><creator>Prasad, Krishna</creator><creator>Suhaimi, Nurfatihah Azlyna Ahmad</creator><creator>Yap, Wei Sheng</creator><creator>Das, Arpita</creator><creator>Banerjee, Pradipta</creator><creator>Ghosh, Nandini</creator><creator>Guith, Tanner</creator><creator>Das, Amitava</creator><creator>Balakrishnan, Sarannya</creator><creator>Candasamy, Mayuren</creator><creator>Mayuren, Jayashree</creator><creator>Palaniveloo, Kishneth</creator><creator>Gupta, Gaurav</creator><creator>Singh, Sachin Kumar</creator><creator>Dua, Kamal</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2609-8849</orcidid><orcidid>https://orcid.org/0000-0002-7507-1159</orcidid><orcidid>https://orcid.org/0000-0001-5567-6663</orcidid><orcidid>https://orcid.org/0000-0002-8665-3074</orcidid><orcidid>https://orcid.org/0000-0002-6745-9815</orcidid><orcidid>https://orcid.org/0000-0003-0466-2602</orcidid><orcidid>https://orcid.org/0000-0002-9036-1963</orcidid><orcidid>https://orcid.org/0000-0003-3823-6572</orcidid></search><sort><creationdate>20220822</creationdate><title>Vaccine for Diabetes—Where Do We Stand?</title><author>Chellappan, Dinesh Kumar ; Bhandare, Richie R. ; Shaik, Afzal B. ; Prasad, Krishna ; Suhaimi, Nurfatihah Azlyna Ahmad ; Yap, Wei Sheng ; Das, Arpita ; Banerjee, Pradipta ; Ghosh, Nandini ; Guith, Tanner ; Das, Amitava ; Balakrishnan, Sarannya ; Candasamy, Mayuren ; Mayuren, Jayashree ; Palaniveloo, Kishneth ; Gupta, Gaurav ; Singh, Sachin Kumar ; Dua, Kamal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-81c831c1d05e829071df2dde575dc770849f7234122adafdc3b67a5525b913993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animal models</topic><topic>Antigens</topic><topic>Apoptosis</topic><topic>Chronic illnesses</topic><topic>Clinical trials</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Disease prevention</topic><topic>Family medical history</topic><topic>Immune system</topic><topic>Immunomodulation</topic><topic>Insulin resistance</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Medical research</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Pathogens</topic><topic>Peptides</topic><topic>Review</topic><topic>Tumor necrosis factor-TNF</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chellappan, Dinesh Kumar</creatorcontrib><creatorcontrib>Bhandare, Richie R.</creatorcontrib><creatorcontrib>Shaik, Afzal B.</creatorcontrib><creatorcontrib>Prasad, Krishna</creatorcontrib><creatorcontrib>Suhaimi, Nurfatihah Azlyna Ahmad</creatorcontrib><creatorcontrib>Yap, Wei Sheng</creatorcontrib><creatorcontrib>Das, Arpita</creatorcontrib><creatorcontrib>Banerjee, Pradipta</creatorcontrib><creatorcontrib>Ghosh, Nandini</creatorcontrib><creatorcontrib>Guith, Tanner</creatorcontrib><creatorcontrib>Das, Amitava</creatorcontrib><creatorcontrib>Balakrishnan, Sarannya</creatorcontrib><creatorcontrib>Candasamy, Mayuren</creatorcontrib><creatorcontrib>Mayuren, Jayashree</creatorcontrib><creatorcontrib>Palaniveloo, Kishneth</creatorcontrib><creatorcontrib>Gupta, Gaurav</creatorcontrib><creatorcontrib>Singh, Sachin Kumar</creatorcontrib><creatorcontrib>Dua, Kamal</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chellappan, Dinesh Kumar</au><au>Bhandare, Richie R.</au><au>Shaik, Afzal B.</au><au>Prasad, Krishna</au><au>Suhaimi, Nurfatihah Azlyna Ahmad</au><au>Yap, Wei Sheng</au><au>Das, Arpita</au><au>Banerjee, Pradipta</au><au>Ghosh, Nandini</au><au>Guith, Tanner</au><au>Das, Amitava</au><au>Balakrishnan, Sarannya</au><au>Candasamy, Mayuren</au><au>Mayuren, Jayashree</au><au>Palaniveloo, Kishneth</au><au>Gupta, Gaurav</au><au>Singh, Sachin Kumar</au><au>Dua, Kamal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccine for Diabetes—Where Do We Stand?</atitle><jtitle>International journal of molecular sciences</jtitle><date>2022-08-22</date><risdate>2022</risdate><volume>23</volume><issue>16</issue><spage>9470</spage><pages>9470-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Diabetes is an endocrinological disorder with a rapidly increasing number of patients globally. Over the last few years, the alarming status of diabetes has become a pivotal factor pertaining to morbidity and mortality among the youth as well as middle-aged people. Current developments in our understanding related to autoimmune responses leading to diabetes have developed a cause for concern in the prospective usage of immunomodulatory agents to prevent diabetes. The mechanism of action of vaccines varies greatly, such as removing autoreactive T cells and inhibiting the interactions between immune cells. Currently, most developed diabetes vaccines have been tested in animal models, while only a few human trials have been completed with positive outcomes. In this review, we investigate the undergoing clinical trial studies for the development of a prototype diabetes vaccine.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>36012735</pmid><doi>10.3390/ijms23169470</doi><orcidid>https://orcid.org/0000-0002-2609-8849</orcidid><orcidid>https://orcid.org/0000-0002-7507-1159</orcidid><orcidid>https://orcid.org/0000-0001-5567-6663</orcidid><orcidid>https://orcid.org/0000-0002-8665-3074</orcidid><orcidid>https://orcid.org/0000-0002-6745-9815</orcidid><orcidid>https://orcid.org/0000-0003-0466-2602</orcidid><orcidid>https://orcid.org/0000-0002-9036-1963</orcidid><orcidid>https://orcid.org/0000-0003-3823-6572</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2022-08, Vol.23 (16), p.9470 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9409121 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Animal models Antigens Apoptosis Chronic illnesses Clinical trials Cytokines Diabetes Diabetes mellitus Disease prevention Family medical history Immune system Immunomodulation Insulin resistance Lymphocytes Lymphocytes T Medical research Morbidity Mortality Pathogens Peptides Review Tumor necrosis factor-TNF Vaccines |
title | Vaccine for Diabetes—Where Do We Stand? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A00%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccine%20for%20Diabetes%E2%80%94Where%20Do%20We%20Stand?&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Chellappan,%20Dinesh%20Kumar&rft.date=2022-08-22&rft.volume=23&rft.issue=16&rft.spage=9470&rft.pages=9470-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23169470&rft_dat=%3Cproquest_pubme%3E2706261215%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2706261215&rft_id=info:pmid/36012735&rfr_iscdi=true |